Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,751 total articles
Rafael Holdings, Inc. announced an exclusive licensing agreement with MIT for a patent covering cyclodextrin use in Alzheimer's patients carrying the ApoE4 gene variant. This expands the intellectual property portfolio for Trappsol® Cyclo™, which has shown promising preclinical effects on cholesterol transport, tau pathology reduction, and cognitiv…
Tenax Therapeutics, a Nasdaq-listed biotech company developing novel cardiopulmonary therapies, announced the appointment of Thomas R. Staab, II as Chief Financial Officer effective May 11, 2026. Mr. Staab brings over 25 years of healthcare and financial leadership experience, previously holding CFO roles at healthcare companies including BioCryst …
Certara, Inc. announced an agreement to sell its Regulatory and Medical Writing business to Veristat for up to $135 million, aiming to sharpen focus and accelerate investments in its Model-Informed Drug Development (MIDD) and Clinical Intelligence platforms. The Regulatory and Medical Writing segment generated $50 million in revenue and $17 million…
Nurix Therapeutics announced encouraging preclinical results from multiple oncology programs at AACR 2026, demonstrating the potential of their targeted protein degradation pipeline. Key programs include the pan-mutant BRAF degrader NRX-0305, CBL-B intramolecular glue inhibitors (NX-1607), and Aurora Kinase A degrader NRX-4972. The data show enhanc…
Geron Corporation, a commercial-stage biopharmaceutical company focused on blood cancer treatments, announced it will release its Q1 2026 financial results and business highlights on May 6, 2026. The company will host a conference call and webcast to discuss these results. Geron is currently advancing its first-in-class telomerase inhibitor RYTELO®…
Ocular Therapeutix, a biopharmaceutical company specializing in retina disease treatments, announced an Investor Day event scheduled for June 17, 2026 in New York City with virtual access available. The event will feature senior leadership and key opinion leaders discussing its pipeline including the Phase 3 trials of AXPAXLI for wet AMD and diabet…
Eupraxia Pharmaceuticals announced it will present clinical data from its ongoing Phase 1b/2 RESOLVE trial of EP-104GI, an investigational long-acting corticosteroid for eosinophilic esophagitis, at the Digestive Disease Week 2026. The company will showcase multiple abstracts demonstrating persistent histological and clinical improvements. Addition…
Steven Madden, Ltd., a fashion-forward footwear and accessories company, announced it will release its first quarter 2026 earnings results on May 6, 2026, accompanied by a management conference call and webcast to discuss the financial performance.
KANZHUN LIMITED, also known as BOSS Zhipin, has announced that it has repurchased shares worth nearly RMB958 million so far in 2026, including RMB27.2 million spent on April 21 alone. This continued buyback activity highlights the company's commitment to enhancing shareholder value.
Amaze Holdings, Inc. has announced the launch of Amaze Live, a next-generation live shopping and community commerce platform enabling creators to sell live across social media, text, websites, and other owned channels. This platform is designed to expand the company's creator commerce ecosystem by providing real-time engagement and conversion oppor…
Taboola announced it will release its first quarter 2026 financial results on May 6, 2026, accompanied by a management conference call and webcast to discuss the earnings and company performance.
Amneal Pharmaceuticals announced its agreement to acquire Kashiv BioSciences, creating a fully integrated global biosimilars platform positioned to capitalize on a $300 billion global biologics loss-of-exclusivity opportunity. The transaction will accelerate Amneal's growth, diversify its portfolio, and enhance its biosimilar pipeline. Additionally…
Lulu’s Fashion Lounge Holdings, a Nasdaq-listed women's clothing brand, will release its Q1 2026 financial results on May 13, 2026. The company will host a conference call and webcast for investors the same day. Lulu’s specializes in modern, feminine apparel at accessible prices and serves customers worldwide.
StoneX Group Inc. announced that it now provides its clients with day-one access to Nickel futures and options listed on the Shanghai Futures Exchange (SHFE) via the Overseas Intermediary route, following regulatory approval. This marks a significant development as SHFE contracts become accessible to international participants, enhancing StoneX's o…
Fortuna Mining Corp., a Canadian precious metals miner listed on the NYSE and TSX, announced it will release its Q1 2026 financial results on May 6, 2026, after market close. The company will hold a conference call on May 7, 2026, to discuss operational and financial performance, inviting analysts, investors, and media to participate. Fortuna opera…
Himax Technologies announced new advancements in its high-contrast dual-edge front-lit LCoS microdisplay at SID Display Week 2026, featuring enhanced contrast, improved optical efficiency, and miniaturized integration for augmented reality glasses. The technology delivers significantly sharper image clarity and dynamic range improvements suitable f…
VEON Ltd., a digital operator listed on NASDAQ, announced that its subsidiary Banglalink in Bangladesh has signed an agreement with Starlink Mobile to integrate direct-to-device satellite connectivity, enhancing network coverage in remote regions. The service rollout begins with messaging in 2026, followed by data services pending regulatory approv…
Woodward, Inc. has partnered with Lufthansa Technik to designate Lufthansa as an Elite Licensed Repair Service Facility for Woodward components on CFM International LEAP-1A and LEAP-1B engines. This agreement expands repair and overhaul capabilities at Lufthansa Technik, enhancing service for operators of Airbus A320neo and Boeing 737 MAX aircraft.…
Maze Therapeutics, a clinical-stage biopharmaceutical company focused on kidney and metabolic diseases, announced an underwritten registered offering of 5.54 million common shares and pre-funded warrants totaling $150 million. The proceeds will primarily advance their drug candidates MZE829 for APOL1-mediated kidney disease and MZE782 for phenylket…
At Sea-Air-Space Expo 2026, Kari Wilkinson, President of Newport News Shipbuilding and HII EVP, highlighted HII's initiatives to expand U.S. shipbuilding capacity by growing its workforce, adopting advanced technologies, and promoting distributed shipbuilding across the country. HII reaffirms its role as America's largest military shipbuilder and a…
Figure Technology Solutions, a leading blockchain-native capital marketplace, announced it will release its Q1 2026 earnings on May 11, 2026, followed by a conference call on May 12. The company highlights its leadership in tokenized asset origination and funding, with a growing ecosystem including HELOCs and blockchain-based lending products.
Home BancShares, Inc., parent company of Centennial Bank, announced a quarterly cash dividend of $0.21 per share for the second quarter, payable on June 3, 2026, consistent with the first quarter payout. The dividend reflects the company's stable financial position and ongoing commitment to returning value to shareholders.
Coherent Corp., a leading global photonics company, announced that it will release its financial results for the third quarter of fiscal year 2026 on May 6 after the NYSE closes. The company will host a live audio webcast to discuss the results, demonstrating its commitment to transparency and investor engagement.
Clearfield, Inc., a Nasdaq-listed leader in community broadband fiber connectivity, announced its fiscal second quarter 2026 results will be released on May 6, 2026, after market close. The company will host a conference call to discuss financial results with investors and provide information through its investor relations website.
Ascentage Pharma announced that six abstracts from clinical studies of its key drug candidates will be presented at the 2026 ASCO Annual Meeting, highlighting clinical progress in oncology drug development. Presentations include rapid oral presentations on Olverembatinib, Lisaftoclax, and Alrizomadlin, underlining the company's ongoing global clini…
